These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 23150473)
1. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. Fox BD; Kahn SR; Langleben D; Eisenberg MJ; Shimony A BMJ; 2012 Nov; 345():e7498. PubMed ID: 23150473 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM; Silva MA; Donovan JL; Kanaan AO Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M BMJ; 2013 Aug; 347():f5133. PubMed ID: 23996149 [TBL] [Abstract][Full Text] [Related]
5. Editor's Choice - Severe Bleeding Risks of Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism: A Network Meta-Analysis of Randomised Controlled Trials. Chen J; Lv M; Wu S; Jiang S; Xu W; Qian J; Chen M; Fang Z; Zeng Z; Zhang J Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):465-474. PubMed ID: 34973879 [TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495 [TBL] [Abstract][Full Text] [Related]
7. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Kakkos SK; Kirkilesis GI; Tsolakis IA Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377 [TBL] [Abstract][Full Text] [Related]
8. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. Gómez-Outes A; Terleira-Fernández AI; Suárez-Gea ML; Vargas-Castrillón E BMJ; 2012 Jun; 344():e3675. PubMed ID: 22700784 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830 [TBL] [Abstract][Full Text] [Related]
10. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M JAMA; 2014 Sep; 312(11):1122-35. PubMed ID: 25226478 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. van der Hulle T; Kooiman J; den Exter PL; Dekkers OM; Klok FA; Huisman MV J Thromb Haemost; 2014; 12(3):320-8. PubMed ID: 24330006 [TBL] [Abstract][Full Text] [Related]
12. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis. Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161 [TBL] [Abstract][Full Text] [Related]
13. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons. Hirschl M; Kundi M Vasa; 2014 Sep; 43(5):353-64. PubMed ID: 25147012 [TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism. Robertson L; Yeoh SE; Ramli A Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Morimoto T; Crawford B; Wada K; Ueda S J Cardiol; 2015 Dec; 66(6):466-74. PubMed ID: 26162944 [TBL] [Abstract][Full Text] [Related]
16. Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism. Kang N; Sobieraj DM Thromb Res; 2014 Jun; 133(6):1145-51. PubMed ID: 24713109 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. Cohen AT; Hamilton M; Bird A; Mitchell SA; Li S; Horblyuk R; Batson S PLoS One; 2016; 11(8):e0160064. PubMed ID: 27487187 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence. Lanitis T; Leipold R; Hamilton M; Rublee D; Quon P; Browne C; Cohen AT Clin Ther; 2016 Mar; 38(3):478-93.e1-16. PubMed ID: 26922297 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials. Sardar P; Chatterjee S; Mukherjee D Drugs; 2013 Jul; 73(11):1171-82. PubMed ID: 23812923 [TBL] [Abstract][Full Text] [Related]
20. Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies. Liu ZY; Zhang HX; Ma LY; Mu GY; Xie QF; Zhou S; Wang ZN; Wang Z; Hu K; Xiang Q; Cui YM BMC Cardiovasc Disord; 2022 Mar; 22(1):105. PubMed ID: 35287588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]